Certain A Shares of Sansure Biotech Inc. are subject to a Lock-Up Agreement Ending on 28-AUG-2023. These A Shares will be under lockup for 1103 days starting from 20-AUG-2020 to 28-AUG-2023.

Details:
The controlling shareholder and actual controller Dai Lizhong, Shareholder Hunan Shengwei Dingli Management Consulting Center (Limited Partnership), Hunan St. Weihuaning Management Consulting Center (Limited Partnership) promised not to transfer nor entrustment of shares to any third party nor repurchase by the company within 36 months since the date of listing of the present shares. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 months from listing, lock-up period will be automatically extended for another 6 months. If there is any case of dividends, bonus shares, capitalization of capital reserve and other similar cases, issue price will be adjusted according to ex-dividend and ex-interests.

The major shareholders of the issuer holding more than 5% of the shares, Anhui Zhidao Investment Co., Ltd., Suzhou Lirui Equity Investment Center (Limited Partnership), other shareholders of the company promised not to transfer nor entrustment of shares to any third party nor repurchase by the company within 12 months since the date of listing of the present shares. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 months from listing, lock-up period will be automatically extended for another 6 months. If there is any case of dividends, bonus shares, capitalization of capital reserve and other similar cases, issue price will be adjusted according to ex-dividend and ex-interests.